Masato Kaida

Title: Masato Kaida: Innovator in Pharmaceutical Tablet Composition

Introduction

Masato Kaida is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of tablet compositions aimed at improving the management of blood sugar levels in diabetics. With a total of 4 patents to his name, Kaida's work reflects a commitment to innovation and health.

Latest Patents

Kaida's latest patents include a tablet composition that contains N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine along with a disintegrant. This composition is designed to rapidly disintegrate in the stomach after administration, allowing for absorption that is not influenced by meals. This innovation is particularly beneficial for inhibiting the rise of blood sugar levels in diabetics after meals. Another patent features a similar tablet composition, emphasizing the use of low substituted hydroxypropylcellulose, which also aims to achieve rapid disintegration and effective absorption.

Career Highlights

Masato Kaida is currently employed at Ajinomoto Co., Ltd., a company known for its advancements in food and pharmaceutical products. His work at Ajinomoto has allowed him to focus on innovative solutions that address critical health issues, particularly in diabetes management.

Collaborations

Kaida has collaborated with notable coworkers such as Akira Yabuki and Takahiko Ando. These partnerships have contributed to the development of his patented technologies and have fostered a collaborative environment for innovation.

Conclusion

Masato Kaida's contributions to pharmaceutical tablet compositions demonstrate his dedication to improving health outcomes for diabetics. His innovative patents reflect a significant advancement in the field, showcasing the importance of research and development in healthcare.